WebSify
Follow us on
login
Print

Dr. Reddy's Q3 net falls 29 pct, lags forecast

Source : REUTERS
Last Updated: Thu, Feb 14, 2013 14:22 hrs
Hamied, chairman and MD of Indian generic drugmaker Cipla, speaks on mobile phone in front of cabinets containing company's products before interview in Mumbai

Dr Reddy's Laboratories , India's No.2 drugmaker by sales, reported a larger-than-expected 29.2 percent drop in quarterly net profit as sales in its key North America market remained muted.

Consolidated net profit fell to 3.63 billion rupees ($67.5 million) in the fiscal third quarter ended December, from 5.13 billion rupees a year earlier, the drugmaker said on Thursday. Income from sales and services grew 3.5 percent to 28.65 billion rupees.

Analysts on an average had forecast a net profit of 4.42 billion rupees on net sales of 29.65 billion rupees, according Thomson Reuters I/B/E/S.

Valued $6 billion, shares in ies were down 1.3 percent to 1,879.30 rupees by 0825 GMT when the Mumbai market was down 0.12 percent.

blog comments powered by Disqus
most popular on facebook
talking point on sify finance